Consequences of periodic α-to-β3 residue replacement for immunological recognition of peptide epitopes

ACS Chemical Biology

Volumn 10, Issue 3, 2015, Pages 844-854

  Cheloha, Ross W ^a   Sullivan, Jeremy A ^a,b   Wang, Tong ^a   Sand, Jordan M ^a   Sidney, John ^c   Sette, Alessandro ^c   Cook, Mark E ^a   Suresh, M ^a   Gellman, Samuel H ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIBODY; BOVINE IMMUNOGLOBULIN; EPITOPE; GAMMA INTERFERON; HAPTEN; PEPTIDE; PHOSPHOLIPASE; POLYCLONAL ANTIBODY; POLYPEPTIDE; PROTEIN BCL 2; T LYMPHOCYTE RECEPTOR; APOPTOSIS REGULATORY PROTEIN; BCL2L11 PROTEIN, HUMAN; BIM PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; OLIGOPEPTIDE; ONCOPROTEIN; PHOSPHOLIPASE A2; PROTEIN BINDING; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHICKEN; CIRCULAR DICHROISM; COMPLEX FORMATION; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENANTIOMER; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOLOGICAL SYNAPSE; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; ANIMAL; ANTIBODY SPECIFICITY; BINDING SITE; CHEMISTRY; CYTOLOGY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; KINETICS; MOLECULAR GENETICS; MOLECULAR MODEL; PROTEIN TERTIARY STRUCTURE; STEREOISOMERISM; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; APOPTOSIS REGULATORY PROTEINS; BCL-2-LIKE PROTEIN 11; BINDING SITES; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HUMANS; KINETICS; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; PHOSPHOLIPASES A2; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; RECEPTORS, ANTIGEN, T-CELL; STEREOISOMERISM; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84925355896     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500888q     Document Type: Article

References (43)

1. Alberts, B. (1998) The cell as a collection of protein machines: Preparing the next generation of molecular biologists Cell 92, 291-294
2. Hunter, T. (2000) Signaling - 2000 and beyond Cell 100, 113-127
3. Overall, C. M. and Blobel, C. P. (2007) In search of partners: Linking extracellular proteases to substrates Nat. Rev. Mol. Cell Biol. 8, 245-257
4. Jung, T., Catalgol, B., and Grune, T. (2009) The proteasomal system Mol. Aspects Med. 30, 191-296
5. Janeway, C. (2005) Immunobiology: The Immune System In Health And Disease; Garland Science Taylor & Francis Group, New York.
6. Wells, J. A. and McClendon, C. L. (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces Nature 450, 1001-1009
7. Leader, B., Baca, Q. J., and Golan, D. E. (2008) Protein therapeutics: A summary and pharmacological classification Nat. Rev. Drug Discovery 7, 21-39
8. Diao, L. and Meibohm, B. (2013) Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides Clin. Pharmacokinet. 52, 855-868
9. Wade, D., Boman, A., Wahlin, B., Drain, C. M., Andreu, D., Boman, H. G., and Merrifield, R. B. (1990) All-D amino acid-containing channel-forming antibiotic peptides Proc. Natl. Acad. Sci. U.S.A. 87, 4761-4765
10. Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., and Barron, A. E. (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc. Natl. Acad. Sci. U.S.A. 105, 2794-2799
11. Rodriguez, J. M. and Hamilton, A. D. (2007) Benzoylurea oligomers: Synthetic foldamers that mimic extended α helices Angew. Chem., Int. Ed. 46, 8614-8617
12. Porter, E. A., Wang, X. F., Lee, H. S., Weisblum, B., and Gellman, S. H. (2000) Antibiotics - Non-haemolytic β-amino-acid oligomers Nature 404, 565-565
13. Haase, H. S., Peterson-Kaufman, K. J., Levengood, S. K. L., Checco, J. W., Murphy, W. L., and Gellman, S. H. (2012) Extending foldamer design beyond α-helix mimicry: α/β-Peptide inhibitors of vascular endothelial growth factor signaling J. Am. Chem. Soc. 134, 7652-7655
14. Cheloha, R. C., Maeda, A., Dean, T., Gardella, T. J., and Gellman, S. H. (2014) Backbone modification of a polypeptide drug produces analogs with altered duration of action in vivo Nat. Biotechnol. 32, 653-655
15. Horne, W. S., Johnson, L. M., Ketas, T. J., Klasse, P. J., Lu, M., Moore, J. P., and Gellman, S. H. (2009) Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers P. Natl. Acad. Sci. U.S.A. 106, 14751-14756
16. Johnson, L. M. and Gellman, S. H. (2013) α-Helix mimicry with α/β-peptides Method Enzymol. 523, 407-429
17. Horne, W. S., Boersma, M. D., Windsor, M. A., and Gellman, S. H. (2008) Sequence-based design of α/β-peptide foldamers that mimic BH3 domains Angew. Chem., Int. Ed. 47, 2853-2856
18. Horne, W. S., Price, J. L., and Gellman, S. H. (2008) Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly Proc. Natl. Acad. Sci. U.S.A. 105, 9151-9156
19. Boersma, M. D., Haase, H. S., Peterson-Kaufman, K. J., Lee, E. F., Clarke, O. B., Colman, P. M., Smith, B. J., Horne, W. S., Fairlie, W. D., and Gellman, S. H. (2012) Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: Analogues of the Bim BH3 domain J. Am. Chem. Soc. 134, 315-323
20. Guichard, G., Zerbib, A., Le Gal, F. A., Hoebeke, J., Connan, F., Choppin, J., Briand, J. P., and Guillet, J. G. (2000) Melanoma peptide MART-1(27-35) analogues with enhanced binding capacity to the human class I histocompatibility molecule HLA-A2 by introduction of a β-amino acid residue: Implications for recognition by tumor-infiltrating lymphocytes J. Med. Chem. 43, 3803-3808
21. Reinelt, S., Marti, M., Dedier, S., Reitinger, T., Folkers, G., de Castro, J. A. L., and Rognan, D. (2001) β-Amino acid scan of a Class I major histocompatibility complex-restricted alloreactive T-cell epitope J. Biol. Chem. 276, 24525-24530
22. Webb, A. I., Dunstone, M. A., Williamson, N. A., Price, J. D., de Kauwe, A., Chen, W. S., Oakley, A., Perlmutter, P., McCluskey, J., Aguilar, M. I., Rossjohn, J., and Purcell, A. W. (2005) T cell determinants incorporating β-amino acid residues are protease resistant and remain immunogenic in vivo J. Immunol. 175, 3810-3818
23. Dali, H., Busnel, O., Hoebeke, J., Bi, L. R., Decker, P., Briand, J. P., Baudy-Floch, M., and Muller, S. (2007) Heteroclitic properties of mixed α- and aza-β(3)-peptides mimicking a supradominant CD4 T cell epitope presented by nucleosome Mol. Immunol. 44, 3024-3036
24. Croft, N. P. and Purcell, A. W. (2011) Peptidomimetics: Modifying peptides in the pursuit of better vaccines Expert Rev. Vaccines 10, 211-226
25. Andersson, I. E., Batsalova, T., Haag, S., Dzhambazov, B., Holmdahl, R., Kihberg, J., and Linusson, A. (2011) (E)-Alkene and ethylene isosteres substantially alter the hydrogen-bonding network in Class II MHC A(q)/glycopeptide complexes and affect T-cell recognition J. Am. Chem. Soc. 133, 14368-14378
26. Unudurthi, S. D., Hotta, K., and Kim, C. Y. (2013) Engineering the polyproline II propensity of a Class II major histocompatibility complex ligand peptide ACS Chem. Biol. 8, 2383-2387
27. Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., and Korsmeyer, S. J. (2002) Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics Cancer Cell 2, 183-192
28. Czabotar, P. E., Lee, E. F., van Delft, M. F., Day, C. L., Smith, B. J., Huang, D. C. S., Fairlie, W. D., Hinds, M. G., and Colman, P. M. (2007) Structural insights into the degradation of Mcl-1 induced by BH3 domains Proc. Natl. Acad. Sci. U.S.A. 104, 6217-6222
29. Trott, D. L., Yang, M., Gonzalez, J., Larson, A. E., Tepp, W. H., Johnson, E. A., and Cook, M. E. (2009) Egg yolk antibodies for detection and neutralization of Clostridium botulinum Type A neurotoxin J. Food. Protect. 72, 1005-1011
30. Dintzis, H. M., Symer, D. E., Dintzis, R. Z., Zawadzke, L. E., and Berg, J. M. (1993) A comparison of the immunogenicity of a pair of enantiomeric proteins Proteins 16, 306-308
31. Tissot, A. C., Ciatto, C., Mittl, P. R. E., Grutter, M. G., and Pluckthun, A. (2000) Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex J. Mol. Biol. 302, 873-885
32. Sullivan, J. A., Kim, E. H., Plisch, E. H., Peng, S. L., and Suresh, M. (2012) FOXO3 regulates CD8 T cell memory by T cell-intrinsic mechanisms PLoS Pathog. 8, 15
33. Rock, K. L., Rothstein, L., and Benacerraf, B. (1992) Analysis of the association of peptides of optimal length to Class-I molecules on the surface of cells Proc. Natl. Acad. Sci. U.S.A. 89, 8918-8922
34. Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., and Dustin, M. L. (1999) The immunological synapse: A molecular machine controlling T cell activation Science 285, 221-227
35. Sidney, J., Southwood, S., Moore, C., Oseroff, C., Pinilla, C., Grey, H. M., and Sette, A. (2013) Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture Curr. Protoc. Immunol. 10.1002/0471142735.im1803s100 Chapter 18; Unit 18.3
36. Achour, A., Michaelsson, J., Harris, R. A., Odeberg, J., Grufman, P., Sandberg, J. K., Levitsky, V., Karre, K., Sandalova, T., and Schneider, G. (2002) A structural basis for LCMV immune evasion: Subversion of H2-D(b) and H2-K(b) presentation of gp33 revealed by comparative crystal structure analyses Immunity 17, 757-768
37. Matsumura, M., Fremont, D. H., Peterson, P. A., and Wilson, I. A. (1992) Emerging principles for the recognition of peptide antigens by MHC Class-I molecules Science 257, 927-934
38. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., Delguercio, M. F., Southwood, S., Kubo, R. T., Chesnut, R. W., Grey, H. M., and Chisari, F. V. (1994) The Relationship between Class-I binding affinity and immunogenicity of potential cytotoxic T-cell J. Immunol. 153, 5586-5592
39. Kotturi, M. F., Peters, B., Buendia-Laysa, F., Sidney, J., Oseroff, C., Botten, J., Grey, H., Buchmeier, M. J., and Sette, A. (2007) The CD8(+) T-cell response to lymphocytic choriomeningitis virus involves the L antigen: Uncovering new tricks for an old virus J. Virol. 81, 4928-4940
40. Kim, Y., Ponomarenko, J., Zhu, Z., Tamang, D., Wang, P., Greenbaum, J., Lundegaard, C., Sette, A., Lund, O., Bourne, P. E., Nielsen, M., and Peters, B. (2012) Immune epitope database analysis resource Nucleic Acids Res. W525-W530
41. Hollie, N. I. and Hui, D. Y. (2011) Group 1B phospholipase A(2) deficiency protects against diet-induced hyperlipidemia in mice J. Lipid. Res. 52, 2005-2011
42. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22, 3099-3108
43. Gulukota, K., Sidney, J., Sette, A., and DeLisi, C. (1997) Two complementary methods for predicting peptides binding major histocompatibility complex molecules J. Mol. Biol. 267, 1258-1267